Status:

COMPLETED

The Relative Prevalence and Severity of Autonomic Nervous System Dysfunction

Lead Sponsor:

University of Alabama at Birmingham

Conditions:

Cardiovascular Autonomic Neuropathy

Diabetic Autonomic Neuropathy

Eligibility:

All Genders

19-70 years

Brief Summary

The purpose of this study is to measure the prevalence and severity of cardiac autonomic neuropathy (CAN), diabetic autonomic neuropathy (DAN) which in non-diabetics is termed advanced nervous system ...

Detailed Description

The purpose of this study is to measure the prevalence and severity of cardiac autonomic neuropathy (CAN), diabetic autonomic neuropathy (DAN) which in non-diabetics is termed advanced nervous system ...

Eligibility Criteria

Inclusion

  • Type I and Type II Diabetic patients 19 or older who are scheduled for elective surgery to improve vision impaired by diabetic retinopathy
  • Patients scheduled during the same time period without diabetes for retinal surgery will serve as an age and gender matched reference group to undergo the non-invasive ANS testing on the day of surgery

Exclusion

  • Inability to stand will only do baseline, deep breathing and Valsalva portions (A-D) of the testing as described in section 8.1
  • Patients with syncope on standing will only do portions A-D of the test
  • Inability to cooperate with deep breathing and Valsalva
  • Tracheoscopy or otherwise not able to perform a Valsalva
  • Not desiring to participate after informed consent
  • Known history of idiopathic dysautonomia
  • Pulmonary difficulties associated with hyperventilation, including acute URI
  • Pacemaker dependent
  • Persistently high intraocular pressure despite treatment
  • Atrial fibrillation
  • Ventricular arrhythmias greater than 10 beats per minute
  • Taking MAO inhibitors

Key Trial Info

Start Date :

June 1 2009

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

May 1 2010

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT00919347

Start Date

June 1 2009

End Date

May 1 2010

Last Update

May 28 2012

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Callahan Eye Foundation Hospital

Birmingham, Alabama, United States, 35233